LEXICON PHARMACEUTICALS, INC.

LXRX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $229.4M

Liabilities Breakdown FY2023

Total Liabilities: $136.3M